Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Assets (2016 - 2025)

Historic Return on Assets for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to 0.16%.

  • Arrowhead Pharmaceuticals' Return on Assets rose 7600.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.16%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.02% for FY2025, which is 6600.0% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Return on Assets stood at 0.16% for Q4 2025, which was up 7600.0% from 0.02% recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Return on Assets registered a high of 0.16% during Q4 2025, and its lowest value of 0.6% during Q1 2024.
  • In the last 5 years, Arrowhead Pharmaceuticals' Return on Assets had a median value of 0.2% in 2022 and averaged 0.26%.
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Return on Assets crashed by -4300bps in 2024, and later skyrocketed by 7600bps in 2025.
  • Arrowhead Pharmaceuticals' Return on Assets (Quarter) stood at 0.27% in 2021, then rose by 28bps to 0.2% in 2022, then crashed by -122bps to 0.44% in 2023, then tumbled by -39bps to 0.6% in 2024, then soared by 126bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q4 2025, 0.02% for Q3 2025, and 0.11% during Q2 2025.